295 related articles for article (PubMed ID: 27400930)
21. Antiretroviral treatment reduces increased CSF neurofilament protein (NFL) in HIV-1 infection.
Mellgren A; Price RW; Hagberg L; Rosengren L; Brew BJ; Gisslén M
Neurology; 2007 Oct; 69(15):1536-41. PubMed ID: 17923616
[TBL] [Abstract][Full Text] [Related]
22. Plasma Concentration of the Neurofilament Light Protein (NFL) is a Biomarker of CNS Injury in HIV Infection: A Cross-Sectional Study.
Gisslén M; Price RW; Andreasson U; Norgren N; Nilsson S; Hagberg L; Fuchs D; Spudich S; Blennow K; Zetterberg H
EBioMedicine; 2016 Jan; 3():135-140. PubMed ID: 26870824
[TBL] [Abstract][Full Text] [Related]
23. Central nervous system penetration effectiveness of antiretroviral drugs and neuropsychological impairment in the Ontario HIV Treatment Network Cohort Study.
Carvalhal A; Gill MJ; Letendre SL; Rachlis A; Bekele T; Raboud J; Burchell A; Rourke SB;
J Neurovirol; 2016 Jun; 22(3):349-57. PubMed ID: 26572786
[TBL] [Abstract][Full Text] [Related]
24. Cognitive dysfunction in HIV encephalitic SCID mice correlates with levels of Interferon-alpha in the brain.
Sas AR; Bimonte-Nelson HA; Tyor WR
AIDS; 2007 Oct; 21(16):2151-9. PubMed ID: 18090041
[TBL] [Abstract][Full Text] [Related]
25. Anemia and Red Blood Cell Indices Predict HIV-Associated Neurocognitive Impairment in the Highly Active Antiretroviral Therapy Era.
Kallianpur AR; Wang Q; Jia P; Hulgan T; Zhao Z; Letendre SL; Ellis RJ; Heaton RK; Franklin DR; Barnholtz-Sloan J; Collier AC; Marra CM; Clifford DB; Gelman BB; McArthur JC; Morgello S; Simpson DM; McCutchan JA; Grant I;
J Infect Dis; 2016 Apr; 213(7):1065-73. PubMed ID: 26690344
[TBL] [Abstract][Full Text] [Related]
26. The role of chemokine C-C motif ligand 2 genotype and cerebrospinal fluid chemokine C-C motif ligand 2 in neurocognition among HIV-infected patients.
Thames AD; Briones MS; Magpantay LI; Martinez-Maza O; Singer EJ; Hinkin CH; Morgello S; Gelman BB; Moore DJ; Heizerling K; Levine AJ
AIDS; 2015 Jul; 29(12):1483-91. PubMed ID: 26244388
[TBL] [Abstract][Full Text] [Related]
27. HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors.
Heaton RK; Franklin DR; Ellis RJ; McCutchan JA; Letendre SL; Leblanc S; Corkran SH; Duarte NA; Clifford DB; Woods SP; Collier AC; Marra CM; Morgello S; Mindt MR; Taylor MJ; Marcotte TD; Atkinson JH; Wolfson T; Gelman BB; McArthur JC; Simpson DM; Abramson I; Gamst A; Fennema-Notestine C; Jernigan TL; Wong J; Grant I; ;
J Neurovirol; 2011 Feb; 17(1):3-16. PubMed ID: 21174240
[TBL] [Abstract][Full Text] [Related]
28. Absence of Cerebrospinal Fluid Signs of Neuronal Injury Before and After Immediate Antiretroviral Therapy in Acute HIV Infection.
Peluso MJ; Valcour V; Ananworanich J; Sithinamsuwan P; Chalermchai T; Fletcher JL; Lerdlum S; Chomchey N; Slike B; Sailasuta N; Gisslén M; Zetterberg H; Spudich S;
J Infect Dis; 2015 Dec; 212(11):1759-67. PubMed ID: 25995196
[TBL] [Abstract][Full Text] [Related]
29. Cerebrospinal fluid human immunodeficiency virus type 1 RNA levels are elevated in neurocognitively impaired individuals with acquired immunodeficiency syndrome. HIV Neurobehavioral Research Center Group.
Ellis RJ; Hsia K; Spector SA; Nelson JA; Heaton RK; Wallace MR; Abramson I; Atkinson JH; Grant I; McCutchan JA
Ann Neurol; 1997 Nov; 42(5):679-88. PubMed ID: 9392566
[TBL] [Abstract][Full Text] [Related]
30. Impact of aging on neurocognitive performance in previously antiretroviral-naive HIV-infected individuals on their first suppressive regimen.
Coban H; Robertson K; Smurzynski M; Krishnan S; Wu K; Bosch RJ; Collier AC; Ellis RJ
AIDS; 2017 Jul; 31(11):1565-1571. PubMed ID: 28471765
[TBL] [Abstract][Full Text] [Related]
31. Cerebrospinal fluid (CSF) CD8+ T-cells that express interferon-gamma contribute to HIV associated neurocognitive disorders (HAND).
Schrier RD; Hong S; Crescini M; Ellis R; Pérez-Santiago J; Spina C; Letendre S;
PLoS One; 2015; 10(2):e0116526. PubMed ID: 25719800
[TBL] [Abstract][Full Text] [Related]
32. Plasma sCD14 is a biomarker associated with impaired neurocognitive test performance in attention and learning domains in HIV infection.
Lyons JL; Uno H; Ancuta P; Kamat A; Moore DJ; Singer EJ; Morgello S; Gabuzda D
J Acquir Immune Defic Syndr; 2011 Aug; 57(5):371-9. PubMed ID: 21646912
[TBL] [Abstract][Full Text] [Related]
33. Measuring HIV-1 RNA and interferon-alpha in the cerebrospinal fluid of AIDS patients: insights into the pathogenesis of AIDS Dementia Complex.
Krivine A; Force G; Servan J; Cabée A; Rozenberg F; Dighiero L; Marguet F; Lebon P
J Neurovirol; 1999 Oct; 5(5):500-6. PubMed ID: 10568887
[TBL] [Abstract][Full Text] [Related]
34. A potential role for interferon-alpha in the pathogenesis of HIV-associated dementia.
Rho MB; Wesselingh S; Glass JD; McArthur JC; Choi S; Griffin J; Tyor WR
Brain Behav Immun; 1995 Dec; 9(4):366-77. PubMed ID: 8903853
[TBL] [Abstract][Full Text] [Related]
35. Randomized double-blind placebo-controlled trial of peptide T for HIV-associated cognitive impairment.
Heseltine PN; Goodkin K; Atkinson JH; Vitiello B; Rochon J; Heaton RK; Eaton EM; Wilkie FL; Sobel E; Brown SJ; Feaster D; Schneider L; Goldschmidts WL; Stover ES
Arch Neurol; 1998 Jan; 55(1):41-51. PubMed ID: 9443710
[TBL] [Abstract][Full Text] [Related]
36. Reversing interferon-alpha neurotoxicity in a HIV-associated neurocognitive disorder mouse model.
Koneru R; Bimonte-Nelson H; Ciavatta V; Haile W; Elmore K; Ward J; Maroun L; Tyor WR
AIDS; 2018 Jul; 32(11):1403-1411. PubMed ID: 29683852
[TBL] [Abstract][Full Text] [Related]
37. Diagnostic and prognostic biomarkers for HAND.
McLaurin KA; Booze RM; Mactutus CF
J Neurovirol; 2019 Oct; 25(5):686-701. PubMed ID: 30607890
[TBL] [Abstract][Full Text] [Related]
38. Cognitive screening in treatment-naïve HIV-infected individuals in Hong Kong - a single center study.
Chan FCC; Chan P; Chan I; Chan A; Tang THC; Lam W; Fong WC; Lee MP; Li P; Chan GHF
BMC Infect Dis; 2019 Feb; 19(1):156. PubMed ID: 30760220
[TBL] [Abstract][Full Text] [Related]
39. Cerebrospinal fluid human immunodeficiency virus type 1 (HIV-1) p24 antigen levels in HIV-1-related dementia.
Royal W; Selnes OA; Concha M; Nance-Sproson TE; McArthur JC
Ann Neurol; 1994 Jul; 36(1):32-9. PubMed ID: 7912918
[TBL] [Abstract][Full Text] [Related]
40. Elevated levels of soluble Fas and Fas ligand in cerebrospinal fluid of patients with AIDS dementia complex.
Sabri F; De Milito A; Pirskanen R; Elovaara I; Hagberg L; Cinque P; Price R; Chiodi F
J Neuroimmunol; 2001 Mar; 114(1-2):197-206. PubMed ID: 11240032
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
